Newsroom

Newsroom

Residual ctDNA after treatment predicts early relapse in patients with early stage non-small cell lung cancer

Literature
Read More

A solid variant of splenic mesothelial cyst, a case report with molecular analysis

Literature
Read More

NeoGenomics To Participate Virtually In Multiple Upcoming Institutional Investor Conferences

Press Release
Read More

Impact of COVID-19 on Delay in Cancer Diagnostic Testing

Literature
Read More

TP53/NPM1-Mutated Acute Myeloid Leukemia as a Molecularly Distinct Disease Entity

Literature
Read More

Jemperli blog post - please share your thoughts!

Blog
Read More

NeoGenomics To Participate In The Bank of America 2021 Health Care Conference

Press Release
Read More

NeoGenomics Reports 9% Revenue Growth to $116 Million in the First Quarter

Press Release
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients